Monster Beverage
MNST · NASDAQ
About MNST
- Employees
- 6,891
- Headquarters
- Corona, California
- Listed
- Dec 9, 1985
- Sector
- Consumer Staples
- Industry
- Beverages
- Website
- monsterbevcorp.com
MNST key statistics
- Market cap
- 91.68B
- Price-earnings ratio
- 43.33
- Dividend yield
- —
- Average volume
- 9.49M
- Volume
- 5.96M
- Open price
- $47.26
- High today
- $47.59
- Low today
- $46.88
- 52 Week high
- $50.17
- 52 Week low
- $32.94
Monster Beverage (MNST) at a glance
As of Oct 20, 2026, Monster Beverage (MNST) shares are priced at $47.04, giving the company a market cap of 91.68B and a price-to-earnings ratio of 43.33.
Today the stock has traded between $46.88 and $47.59. The current price is 0.3% above the day's low and 1.2% below its high.
Volume so far is 5.96M shares, below the average of 9.49M shares a day.
Over the past year Monster Beverage has ranged from $32.94 to $50.17, and now sits 82% of the way up that range.
Monster Beverage met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $0.30 per share against an estimate of $0.2967.
The average analyst price target is $52.29, 11.2% above the current price, from 16 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy62.5%
- Hold37.5%
- Sell0.0%
- Low
- $36.18
- Now
- $47.04
- High
- $75.96
MNST earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 6.1% on average.
- Q3 FY24: reported $0.20 per share against an estimate of $0.218
- Q4 FY24: reported $0.19 per share against an estimate of $0.2043
- Q1 FY25: reported $0.235 per share against an estimate of $0.2355
- Q2 FY25: reported $0.255 per share against an estimate of $0.245
- Q3 FY25: reported $0.28 per share against an estimate of $0.2463
- Q4 FY25: reported $0.255 per share against an estimate of $0.2465
- Q1 FY26: reported $0.29 per share against an estimate of $0.2677
- Q2 FY26: reported $0.30 per share against an estimate of $0.2967
MNST news
- Piero Cingari
- Chris Katje
NFL Legend Rob Gronkowski Didn't Want Stock For His Drink Endorsement — Years Later It Paid A 'Huge Check'
- Radhika Anilkumar Nadig
Trump's Surgeon General Pick Has Tobacco, Cola Stocks In Portfolio Even as Robert Kennedy Jr. Wages War On Sugary Drinks, Processed Food
'Trump’s Surgeon General Pick Invested in Tobacco, McDonald’s' - Bloomberg News
- Piero Cingari
S&P 500 Eyes Records, Fed Hike Odds Near 51% Before CPI: Stock Market Today
- Chris Katje
This Congressman Slammed Elon Musk — Then Bought SpaceX Stock
- Press releasePRNewswire
Monster Energy Athletes Claim Victory and Podium Spots on Day 1 of X Games New Orleans 2026
- Chandrima Sanyal
More Bark, More Beta: Corgi Debuts 31 Single-Stock ETFs Covering Nvidia, Tesla And More
Similar companies
Companies in the same industry as Monster Beverage
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.